MDT Earnings & Financial Statements
Medtronic plc
$94.23
+$1.22(+1.31%)
73
Overall
100
Value
70
Tech
50
Quality
Market Cap
$120.53B
Volume
49.86M
52W Range
$73.31 - $106.33
Target Price
$102.40
MDT earnings and financial statements: Medtronic plc's income statement, balance sheet and cash flow statement, annual and quarterly.
MDT Annual Financial Statements
| Fiscal year | 2026 | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Revenue | $36.36B | $33.54B | $32.36B | $31.23B | $31.69B |
| Cost of revenue | -$12.72B | -$11.63B | $11.22B | $10.72B | $10.14B |
| Operating income | $6.47B | $5.96B | $5.14B | $5.83B | $5.75B |
| EBITDA | $5.78B | $5.89B | $8.20B | $8.70B | $8.78B |
| Net income | $4.80B | $4.66B | $3.68B | $3.76B | $5.04B |
| EPS (diluted) | $3.73 | $3.61 | $2.76 | $2.82 | $3.73 |
| Fiscal year | 2026 | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Total assets | $93.03B | $91.68B | $89.98B | $90.95B | $90.98B |
| Total liabilities | $42.96B | $43.42B | $39.56B | $39.28B | $38.26B |
| Shareholders’ equity | $49.46B | $48.02B | $50.21B | $51.48B | $52.55B |
| Cash and equivalents | $1.95B | $2.22B | $1.28B | $1.54B | $3.71B |
| Long-term debt | $26.17B | $25.64B | $23.93B | $24.34B | $20.37B |
| Fiscal year | 2026 | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Operating cash flow | $7.33B | $7.04B | $6.79B | $6.04B | $7.35B |
| Capital expenditure | -$1.90B | -$1.86B | -$1.59B | -$1.46B | -$1.37B |
| Free cash flow | $5.43B | $5.18B | $5.20B | $4.58B | $5.98B |
| Dividends paid | $3.64B | $3.59B | $3.67B | $3.62B | $3.38B |
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | MDT | $94.23 | +1.3% | 49.86M |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |